160 related articles for article (PubMed ID: 38066031)
1. Reproducible and clinically translatable deep neural networks for cervical screening.
Ahmed SR; Befano B; Lemay A; Egemen D; Rodriguez AC; Angara S; Desai K; Jeronimo J; Antani S; Campos N; Inturrisi F; Perkins R; Kreimer A; Wentzensen N; Herrero R; Del Pino M; Quint W; de Sanjose S; Schiffman M; Kalpathy-Cramer J
Sci Rep; 2023 Dec; 13(1):21772. PubMed ID: 38066031
[TBL] [Abstract][Full Text] [Related]
2. REPRODUCIBLE AND CLINICALLY TRANSLATABLE DEEP NEURAL NETWORKS FOR CANCER SCREENING.
Ahmed SR; Befano B; Lemay A; Egemen D; Rodriguez AC; Angara S; Desai K; Jeronimo J; Antani S; Campos N; Inturrisi F; Perkins R; Kreimer A; Wentzensen N; Herrero R; Del Pino M; Quint W; de Sanjose S; Schiffman M; Kalpathy-Cramer J
Res Sq; 2023 Mar; ():. PubMed ID: 36909463
[TBL] [Abstract][Full Text] [Related]
3. Deep learning based cervical screening by the cross-modal integration of colposcopy, cytology, and HPV test.
Fu L; Xia W; Shi W; Cao GX; Ruan YT; Zhao XY; Liu M; Niu SM; Li F; Gao X
Int J Med Inform; 2022 Mar; 159():104675. PubMed ID: 34979436
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study.
Bao H; Bi H; Zhang X; Zhao Y; Dong Y; Luo X; Zhou D; You Z; Wu Y; Liu Z; Zhang Y; Liu J; Fang L; Wang L
Gynecol Oncol; 2020 Oct; 159(1):171-178. PubMed ID: 32814641
[TBL] [Abstract][Full Text] [Related]
5. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
6. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
Canfell K; Saville M; Caruana M; Gebski V; Darlington-Brown J; Brotherton J; Heley S; Castle PE
BMJ Open; 2018 Jan; 8(1):e016700. PubMed ID: 29374658
[TBL] [Abstract][Full Text] [Related]
7. Smartphone Use for Cervical Cancer Screening in Low-Resource Countries: A Pilot Study Conducted in Madagascar.
Catarino R; Vassilakos P; Scaringella S; Undurraga-Malinverno M; Meyer-Hamme U; Ricard-Gauthier D; Matute JC; Petignat P
PLoS One; 2015; 10(7):e0134309. PubMed ID: 26222772
[TBL] [Abstract][Full Text] [Related]
8. [A study of cervical cancer screening algorithms].
Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
[TBL] [Abstract][Full Text] [Related]
9. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of combined molecular and morphology-based triage for HPV-positive women in routine cervical cancer screening services from Colombia.
Murillo R; Gamboa O; Hernández G; González M; Olejua P; Molano M; Wiesner C
Prev Med; 2021 Dec; 153():106801. PubMed ID: 34508733
[TBL] [Abstract][Full Text] [Related]
11. [Use of human papilloma virus testing in primary cervical cancer screening in rural Madagascar].
Dumont A; Bessières N; Razafindrafara G; Ravit M; Benbassa A
Rev Epidemiol Sante Publique; 2019 Apr; 67(2):120-125. PubMed ID: 30448093
[TBL] [Abstract][Full Text] [Related]
12. Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56-60.
Lamin H; Eklund C; Elfström KM; Carlsten-Thor A; Hortlund M; Elfgren K; Törnberg S; Dillner J
BMJ Open; 2017 May; 7(5):e014788. PubMed ID: 28566363
[TBL] [Abstract][Full Text] [Related]
13. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
Tiews S; Steinberg W; Schneider W; Hanrath C
J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
[TBL] [Abstract][Full Text] [Related]
14. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
[TBL] [Abstract][Full Text] [Related]
15. Performance of visual inspection of the cervix with acetic acid (VIA) for triage of HPV screen-positive women: results from the ESTAMPA study.
Baena A; Mesher D; Salgado Y; Martínez S; Villalba GR; Amarilla ML; Salgado B; Flores B; Bellido-Fuentes Y; Álvarez-Larraondo M; Valls J; Lora O; Virreira-Prout G; Figueroa J; Turcios E; Soilán AM; Ortega M; Celis M; González M; Venegas G; Terán C; Ferrera A; Mendoza L; Kasamatsu E; Murillo R; Wiesner C; Broutet N; Luciani S; Herrero R; Almonte M;
Int J Cancer; 2023 Apr; 152(8):1581-1592. PubMed ID: 36451311
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
[TBL] [Abstract][Full Text] [Related]
17. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
18. Deep Convolution Neural Network for Malignancy Detection and Classification in Microscopic Uterine Cervix Cell Images.
P B S; Faruqi F; K S H; Kudva R
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3447-3456. PubMed ID: 31759371
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Cervical Cancer in Low-Resource African Settings.
Mulongo M; Chibwesha CJ
Obstet Gynecol Clin North Am; 2022 Dec; 49(4):771-781. PubMed ID: 36328679
[TBL] [Abstract][Full Text] [Related]
20. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
